Wax-matrix tablet for time-dependent colon-specific delivery system of Sophora flavescens Aiton: Preparation and in vivo evaluation

Drug Development and Industrial Pharmacy

Volumn 35, Issue 2, 2009, Pages 224-233

  Zou, Meijuan ^a   Wang, Yue ^a   Xu, Caihong ^a   Cheng, Gang ^a   Ren, Jungang ^b   Wu, Gaolei ^b  

^a SHENYANG PHARMACEUTICAL UNIVERSITY   (China)

^b HARBIN UNIVERSITY OF COMMERCE   (China)

Author keywords

In vivo evaluation; Preparation; Sophora flavescens Aiton; Time dependent colon specific delivery; Wax matrix

Indexed keywords

ACYLGLYCEROL; CARBOXYMETHYLSTARCH SODIUM; POLYMER; SODIUM CHLORIDE; SOPHORA FLAVESCENS EXTRACT;

ARTICLE; DRUG ABSORPTION; DRUG COATING; DRUG DELIVERY SYSTEM; DRUG RELEASE; DRUG SYNTHESIS; IN VITRO STUDY; IN VIVO STUDY; MATRIX TABLET; TIMED DRUG RELEASE;

ALKALOIDS; ANIMALS; COLON; DELAYED-ACTION PREPARATIONS; DOGS; DRUG COMBINATIONS; DRUG COMPOUNDING; DRUG DELIVERY SYSTEMS; DRUGS, CHINESE HERBAL; GLYCERIDES; HYDROGEN-ION CONCENTRATION; INTESTINAL ABSORPTION; MALE; METHACRYLATES; PLANTS, MEDICINAL; POLYMERS; QUINOLIZINES; SODIUM CHLORIDE; SOPHORA; STARCH; TABLETS, ENTERIC-COATED; WAXES;

EID: 60749108971     PISSN: 03639045     EISSN: 15205762     Source Type: Journal    
DOI: 10.1080/03639040802258854     Document Type: Article

References (30)

1. Cao, Q. R., Kim, T. W., & Lee, B. J. (2007). Photoimages and the release characteristics of lipophilic matrix tablets containing highly water-soluble potassium citrate with high drug loadings. Int. J. Pharm., 339, 19-24.
2. Carceller, E., Salas, J., Merlos, M., Giral, M., Ferrando, R., Escamilla, I., Ramis, J., Garcia-Rafanell, J., & Forn, J. (2001). Novel azo derivatives as prodrugs of 5-aminosalicylic acid and amino derivatives with potent platelet activating factor antagonist activity. J. Med. Chem., 44, 3001-3013.
3. Cheng, G., An, F., Zou, M. J., Sun, J., Hao, X. H., & He, Y. X. (2004). Studies on the diclofenac sodium time-dependent and 5-aminosalicylic acid pH-dependent oral colon-specific drug delivery systems. WJG, 12, 1769-1774.
4. Chourasia, M. K., & Jain, S. K. (2003). Pharmaceutical approaches to colon targeted drug delivery systems. J. Pharm. Pharm. Sci., 6, 33-66.
5. Conte, U., Colombo, P., La Manna, A., Gazzaniga, A., Sangalli, M. E., & Giunchedi, P. (1989). A new ibuprofen pulsed release oral dosage form. Drug Dev. Ind. Pharm., 15(14-16), 2583.
6. Fan, T. Y., Wei, S. L., Yan, W. W., Chen, D. B., & Li, J. (2001). An investigation of pulsatile release tablets with ethylcellulose and Eudragit L as film coating materials and cross-linked polyvinylpyrrolidone in the core tablets. J. Control. Release, 77, 245-251.
7. Gazzaniga, A., Iamartino, P., Maffione, G., & Sangall, M. E. (1994). Oral delayed release system for colonic specific delivery. Int. J. Pharm., 108, 77-84.
8. Gupta, V. K., Beckert, T. E., & Price, J. C. (2001). A novel pH- and time-based multi-unit potential colonic drug delivery system. I. Development. Int. J. Pharm., 213(1-2), 83-91.
9. Halsas, M., Hietala, J., Veski, P., Jurjenson, H., & Marvola, M. (1999). Morning versus evening dosing of ibuprofen using conventional and time controlled release formulations. Int. J. Pharm., 189, 179-185.
10. Halsas, M., Penttinen, T., Veski, P., Jurjenson, H., & Marvola, M. (2001). Time-controlled release pseudoephedrine tablets: Bioavailability and in vitro/in vivo correlations. Pharmazie., 56, 718-723.
11. Jeffery, W. M., & Hernry, H. F. (1996). Mathematical comparision of dissolution profiles. Pharm. Tech., 20, 64-74.
12. Khan, M. Z., Prebeg, Z., & Kurjakovic, N. (1999). A pH-dependent colon targeted oral drug delivery system using methacrylic acid copolymers I. Manipulation of drug release using Eudragit L100-55 and Eudragit S100 combinations. J. Control. Release, 58, 215-222.
13. Khan, M. Z., Stedul, H. P., & Kurjakovic, N. (2000). A pH-dependent colon targeted oral drug delivery system using methacrylic acid copolymers. II. Manipulation of drug release using Eudragit L100 and Eudragit S100 combinations. Drug Dev. Ind. Pharm., 26, 549-554.
14. Kinget, R., Kalala, W., Vervoort, L., & van den Mooter, G. (1998). Colonic drug targeting. J. Drug Target., 6, 129-149.
15. Krogars, K., Heinamaki, J., Vesalahti, J., Marvola, M., Antikainen, O., & Yliruusi, J. (2000). Extrusion-spheronization of pH-sensitive polymeric matrix pellete for possible colonic drug delivery. Int. J. Pharm., 199, 187-194.
16. Liu, H., Yang, X.-G., Nie, S.-F., Wei, L.-L., Zhou, L.-L., Liu, H., Tang, R., & Pan, W.-S. (2007). Chitosan-based controlled porosity osmotic pump for colon-specific delivery system: Screening of formulation variables and in vitro investigation. Int. J. Pharm., 332, 115-124.
17. Liu, M., Liu, X. Y., & Cheng, J. F. (2003). Advance in the pharmacological research on matrine. China J. Chinese Materia Medica, 28, 801-804.
18. Li, Z. R. (2003). Pharmacological and clinical advances of oxymatrine. West China J. Pharm. Sci., 18, 435-437.
19. Muraoka, M., Hu, Z. P., Shimokawa, T., Sekino, S. I., Kurogoshi, R. E., Kuboi, Y., Yoshikawa, Y., & Takada, K. (1998). Evaluation of intestinal pressure-controlled colon delivery capsule containing caffeine as a model drug in human volunteers. J. Control. Release, 52, 119-129.
20. Pozzi, F., Furlani, P., Gazzaniga, A., Davis, S. S., & Wilding, I. R. (1994). The time clock system: A new oral dosage form for fast and complete release of drug after a predetermined lag time. J. Control. Release, 31, 99.
21. Rao, S. S., & Ritschel, W. A. (1992). Development and in vitro/in vivo evaluation of a colonic release capsule of vasopressin. Int. J. Pharm., 86, 35-41.
22. Sinha, V. R., & Kumria, R. (2001). Polysaccharides in colon-specific drug delivery. Int. J. Pharm., 224, 19-38.
23. Soodabeh, D., Jalal, H., & Abbas, K. (1999). Release of 5-ASA from acrylic type polymeric prodrugs designed for colon-specific drug delivery. J. Control. Release, 58, 279-287.
24. Takada, K. (1997). Controlled-release preparations. United States Patent: 5,637,319 (1225 of 2331), 7 10.
25. Tozaki, H., Fujita, T., Odoriba, T., Terabe, A., Okabe, S., Muranishi, S., & Yamamoto, A. (1999). Validation of a pharmacokinetic model of colon specific drug delivery and the therapeutic effects of chitosan capsules containing 5-aminosalicylic acid on 2,4,6-trinitrobenzene-sulphonic acid-induced colitis in rats. J. Pharm. Pharmacol., 51, 1107-1112.
26. Wang, S., Wang, G., Li, X., Sun, J., Ma, R., & Sheng, L. (2005). Simultaneous determination of oxymatrine and its active metabolite matrine in dog plasma by liquid chromatography-mass spectrometry and its application to pharmacokinetic studies. J. Chromatogr. B Analyt. Technol. Biomed. Life Sci., 817(2), 319-325.
27. Watts, P. J., & Lllum, L. (1997). Colonic drug delivery. Drug Dev. Ind. Pharm., 23, 893-913.
28. Xia, J., & Liu, C. (2000). The statistical evaluation and analysis of in vitro dissolution of solid preparation. J. Chinese Pharm., 35, 345-349.
29. Yang, L., Chu, J. S., & Fix, J. A. (2002). Colon-specific drug delivery: New approaches and in vitro/in vivo evaluation. Int. J. Pharm., 235, 1-15.
30. Yonezawa, Y., Ishida, S., & Sunada, H. (2005). Release from or through a wax matrix system. VI. Analysis and prediction of the entire release process of the wax matrix tablet. Chem. Pharm. Bull., 53, 915-918.